These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 24561328)
41. Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvement. Teschke R; Frenzel C; Wolff A; Herzog J; Glass X; Schulze J; Eickhoff A Ann Hepatol; 2012; 11(4):500-12. PubMed ID: 22700632 [TBL] [Abstract][Full Text] [Related]
42. Publication bias and outcome reporting bias: agomelatine as a case example. Howland RH J Psychosoc Nurs Ment Health Serv; 2011 Sep; 49(9):11-4. PubMed ID: 21846075 [TBL] [Abstract][Full Text] [Related]
43. Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database. Petronijevic M; Ilic K; Suzuki A Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):416-23. PubMed ID: 21370308 [TBL] [Abstract][Full Text] [Related]
44. Hepatic adverse drug reactions: a case/non-case study in Italy. Motola D; Vargiu A; Leone R; Cocci A; Salvo F; Ros B; Meneghelli I; Venegoni M; Cutroneo PM; Vaccheri A; Velo G; Montanaro N Eur J Clin Pharmacol; 2007 Jan; 63(1):73-9. PubMed ID: 17119945 [TBL] [Abstract][Full Text] [Related]
45. The use of antidepressants in clinical practice: focus on agomelatine. McAllister-Williams RH; Baldwin DS; Haddad PM; Bazire S Hum Psychopharmacol; 2010 Mar; 25(2):95-102. PubMed ID: 20196187 [TBL] [Abstract][Full Text] [Related]
46. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting. Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028 [TBL] [Abstract][Full Text] [Related]
47. [Antidepressive agents and hypertension: A case/no-case study in French pharmacovigilance database]. Hofferer A; Dolladille C; Chretien B; Sassier M; Laugier D; Atzenhoffer M; Bagheri H; Alexandre J; Fedrizzi S; Humbert X Encephale; 2022 Aug; 48(4):404-408. PubMed ID: 34311965 [TBL] [Abstract][Full Text] [Related]
48. Hepatic adverse reactions associated with nefazodone. Stewart DE Can J Psychiatry; 2002 May; 47(4):375-7. PubMed ID: 12025437 [TBL] [Abstract][Full Text] [Related]
49. Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database. Bossard JB; Ponté C; Dupouy J; Lapeyre-Mestre M; Jouanjus E Clin Drug Investig; 2016 Sep; 36(9):735-742. PubMed ID: 27300651 [TBL] [Abstract][Full Text] [Related]
50. Drug related falls: a study in the French Pharmacovigilance database. Souchet E; Lapeyre-Mestre M; Montastruc JL Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):11-6. PubMed ID: 15508129 [TBL] [Abstract][Full Text] [Related]
52. Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French pharmacovigilance database. Trenque T; Herlem E; Auriche P; Dramé M Drug Saf; 2011 Dec; 34(12):1161-6. PubMed ID: 22077504 [TBL] [Abstract][Full Text] [Related]
53. No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain. D'Incau P; Lapeyre-Mestre M; Carvajal A; Donati M; Salado I; Rodriguez L; Sáinz M; Escudero A; Conforti A Fundam Clin Pharmacol; 2014 Jun; 28(3):342-8. PubMed ID: 23617454 [TBL] [Abstract][Full Text] [Related]
54. Relationship between structural alerts in NSAIDs and idiosyncratic hepatotoxicity: an analysis of spontaneous report data from the WHO database. Jessurun N; van Puijenbroek E Drug Saf; 2015 May; 38(5):511-5. PubMed ID: 25787329 [TBL] [Abstract][Full Text] [Related]
55. Heart rhythm disturbances associated with rupatadine: a case series from the Spanish and Portuguese pharmacovigilance systems. Carvajal A; Macías D; Salado I; Sáinz M; Ortega S; Campo C; García del Pozo J; Martín Arias LH; Velasco A; Gonçalves S; Pombal R; Carmona R Clin Pharmacol Ther; 2009 May; 85(5):481-4. PubMed ID: 19225450 [TBL] [Abstract][Full Text] [Related]
56. Agomelatine in depression. Smeraldi E; Delmonte D Expert Opin Drug Saf; 2013 Nov; 12(6):873-80. PubMed ID: 24033095 [TBL] [Abstract][Full Text] [Related]
57. Nimesulide-induced hepatotoxicity: A systematic review and meta-analysis. Kwon J; Kim S; Yoo H; Lee E PLoS One; 2019; 14(1):e0209264. PubMed ID: 30677025 [TBL] [Abstract][Full Text] [Related]
58. Risk of bleeding related to selective and non-selective serotonergic antidepressants: a case/non-case approach using data from two pharmacovigilance databases. Gahr M; Zeiss R; Lang D; Connemann BJ; Hiemke C; Freudenmann RW; Schönfeldt-Lecuona C Pharmacopsychiatry; 2015 Jan; 48(1):19-24. PubMed ID: 25376976 [TBL] [Abstract][Full Text] [Related]
59. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006. Lapeyre-Mestre M; Grolleau S; Montastruc JL; Fundam Clin Pharmacol; 2013 Apr; 27(2):223-30. PubMed ID: 21929527 [TBL] [Abstract][Full Text] [Related]
60. Excessive sweating induced by interaction between agomelatine and duloxetine hydrochloride: case report and review of the literature. Štuhec M Wien Klin Wochenschr; 2015 Sep; 127(17-18):703-6. PubMed ID: 25576334 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]